Optimal interruption time of dabigatran oral administration to ablation (O-A time) in patients with atrial fibrillation: Integrated analysis of 2 randomized controlled clinical trials.
暂无分享,去创建一个
H. Calkins | K. Aonuma | A. Nogami | M. Gosho | M. Ieda | Y. Sekiguchi | M. Igarashi | H. Yamasaki | A. Kimata | Tomohiro Ohigashi | Miyako Igarashi